High emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
High emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil ; volume:6 ; number:1 ; day:22 ; month:7 ; year:2009 ; pages:1-2 ; date:7.2009
Retrovirology ; 6, Heft 1 (22.7.2009), 1-2, 7.2009
- Urheber
-
Pilotto, Jose Henrique
- Beteiligte Personen und Organisationen
-
Grinsztejn, Beatriz
Veloso, Valdilea
Couto-Fernandez, Jose Carlos
Rodrigues-Pedro, Adriana
Velasco-de-Castro, Carlos Augusto
Ribeiro, Jorge Eurico
Khalili, Ruth
Muri, Sandra
Ismerio, Ronaldo
Courrier, Judith
Morgado, Mariza G.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S1-O14
- URN
-
urn:nbn:de:1111-201608075553
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pilotto, Jose Henrique
- Grinsztejn, Beatriz
- Veloso, Valdilea
- Couto-Fernandez, Jose Carlos
- Rodrigues-Pedro, Adriana
- Velasco-de-Castro, Carlos Augusto
- Ribeiro, Jorge Eurico
- Khalili, Ruth
- Muri, Sandra
- Ismerio, Ronaldo
- Courrier, Judith
- Morgado, Mariza G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study
Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis
Highly active antiretroviral treatment (HAART) interruption leads to an increase in mitochondrial DNA content in HIV-infected children
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Mother-to-child signaling through breast milk biomolecules
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Stress in patients submitted to drug therapy
Stress in patients submitted to drug therapy
O213 CD4-guided STI in patients responding to HAART
Prevention of mother-to-child HIV transmission program in Iran
Assessment of mother-to-child HIV prevention program in Albania
Early diagnosis of HIV-1 infection in newborns, in the context of prevention of mother-to-child transmission with HAART (Perinatal Cohort ANRS Co 01)
Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study
Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis
Highly active antiretroviral treatment (HAART) interruption leads to an increase in mitochondrial DNA content in HIV-infected children
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Mother-to-child signaling through breast milk biomolecules
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Stress in patients submitted to drug therapy
Stress in patients submitted to drug therapy
O213 CD4-guided STI in patients responding to HAART
Prevention of mother-to-child HIV transmission program in Iran
Assessment of mother-to-child HIV prevention program in Albania
Early diagnosis of HIV-1 infection in newborns, in the context of prevention of mother-to-child transmission with HAART (Perinatal Cohort ANRS Co 01)
Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study
Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis
Highly active antiretroviral treatment (HAART) interruption leads to an increase in mitochondrial DNA content in HIV-infected children
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Mother-to-child signaling through breast milk biomolecules
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
Stress in patients submitted to drug therapy
Stress in patients submitted to drug therapy
O213 CD4-guided STI in patients responding to HAART
Prevention of mother-to-child HIV transmission program in Iran
Assessment of mother-to-child HIV prevention program in Albania